Update on clinical research and state of the art management of patients with advanced sarcomas and GIST

Sarcomas constitute a rare group of malignancies. According to histology, different treatment options are effective. For gastrointestinal stromal tumours (GISTs), targeted treatment with imatinib controls about 20% of advanced or metastatic disease, whereas chemotherapy is more effective for the res...

Descripción completa

Detalles Bibliográficos
Autores principales: Metaxas, Yannis, Oikonomopoulos, Georgios, Pentheroudakis, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070248/
https://www.ncbi.nlm.nih.gov/pubmed/27843616
http://dx.doi.org/10.1136/esmoopen-2016-000065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070248/
https://www.ncbi.nlm.nih.gov/pubmed/27843616
http://dx.doi.org/10.1136/esmoopen-2016-000065

Ejemplares similares